Clinical Trial Update: Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated whether adding tenofovir/emtricitabine to HIV-1–infected patients with dyslipidemia and suppressed viral load on ritonavir-boosted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Ritonavir-boosted protease inhibitors (ritonavir-boosted protease inhibitors)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV, Dyslipidemia | Phase 4 | Status: COMPLETED